{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Amyotrophic lateral sclerosis or motor neuron disease",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_riluzole",
          "name": "Riluzole"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_edaravone",
          "name": "Edaravone"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_nerinetide",
          "name": "Nerinetide"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_tirasemtiv",
          "name": "Tirasemtiv"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_nusinersen",
          "name": "Nusinersen"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_lithium",
          "name": "Lithium"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_bicalutamide",
          "name": "Bicalutamide"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_dexpramipexole",
          "name": "Dexpramipexole"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_dantrolene",
          "name": "Dantrolene"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_sodium_phenylbutyrate",
          "name": "Sodium phenylbutyrate"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_amx0035",
          "name": "AMX0035"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_cilostazol",
          "name": "Cilostazol"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 3
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot_riluzole",
          "type": "Target",
          "label": "Riluzole Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_edaravone",
          "type": "Target",
          "label": "Edaravone Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_nerinetide",
          "type": "Target",
          "label": "Nerinetide Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_tirasemtiv",
          "type": "Target",
          "label": "Tirasemtiv Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_nusinersen",
          "type": "Target",
          "label": "Nusinersen Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_lithium",
          "type": "Target",
          "label": "Lithium Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "Potential Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv",
          "type": "Phenotype",
          "label": "Adverse Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_riluzole",
          "target": "n_ot_riluzole",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "考虑可能的旁路效应"
        },
        {
          "source": "drug_edaravone",
          "target": "n_ot_edaravone",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "考虑可能的旁路效应"
        },
        {
          "source": "drug_nerinetide",
          "target": "n_ot_nerinetide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "考虑可能的旁路效应"
        },
        {
          "source": "drug_tirasemtiv",
          "target": "n_ot_tirasemtiv",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "考虑可能的旁路效应"
        },
        {
          "source": "drug_nusinersen",
          "target": "n_ot_nusinersen",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "考虑可能的旁路效应"
        },
        {
          "source": "drug_lithium",
          "target": "n_ot_lithium",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "考虑可能的旁路效应"
        },
        {
          "source": "n_ot_riluzole",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路关联"
        },
        {
          "source": "n_ot_edaravone",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路关联"
        },
        {
          "source": "n_ot_nerinetide",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路关联"
        },
        {
          "source": "n_ot_tirasemtiv",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路关联"
        },
        {
          "source": "n_ot_nusinersen",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路关联"
        },
        {
          "source": "n_ot_lithium",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路关联"
        },
        {
          "source": "n_rp",
          "target": "n_adv",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "潜在的导致不良效应的路径"
        },
        {
          "source": "n_adv",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果这个风险成立，将抵消净获益"
        }
      ],
      "set_weights": [],
      "conflict_hotspots": [
        {
          "topic": "疗效与副作用的平衡",
          "pro_nodes": [
            "drug_riluzole",
            "drug_edaravone",
            "drug_nerinetide",
            "drug_tirasemtiv",
            "drug_nusinersen",
            "drug_lithium",
            "drug_bicalutamide",
            "drug_dexpramipexole",
            "drug_dantrolene",
            "drug_sodium_phenylbutyrate",
            "drug_amx0035",
            "drug_cilostazol"
          ],
          "con_nodes": [
            "n_adv"
          ],
          "note": "潜在的治疗效果与副作用的平衡问题"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "存在副作用的风险，可能抵消收益。",
        "confidence": "high"
      },
      {
        "id": "K2",
        "text": "没有明确的长期疗效证据，风险收益比不明。",
        "confidence": "high"
      }
    ],
    "assumptions_challenged": [
      "药物的靶向作用是否能均匀实现",
      "对疾病核心机制的影响是否足够显著"
    ],
    "falsification_tests": [
      "是否有证据显示能显著降低 ALS 患者的病程进展？",
      "是否存在大量临床数据验证疗效与副作用的真实比率？"
    ],
    "next_focus_for_pi": [
      "要求对每种药物的独特副作用进行深入分析",
      "再次评估风险链以及所有相关假设"
    ]
  }
}